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0954-6111/00/001011+07 $35?00/0latory causing histamine release from peripheral blood
basophils, IL-8 release from neutrophils, and superoxide
anion production by neutrophils. However, MBPH is
significantly less potent than MBP in its ability to stimulate
LTC4 release from basophils.
The amino acid sequences of MBP and MBPH along
with the sequences of two forms of guinea pig MBP, mouse
MBP and rat MBP are shown in Fig. 1. The sequence
similarities among these molecules suggest a gene duplica-
tion event occurring early during mammalian evolution
because guinea pigs have two pro-MBP genes. However,
both forms of guinea pig MBP have a characteristically
high pI in contrast to MBPH. Therefore, MBPH may be
evolving toward a new function or drifting away from a
previous function.
A panel of monoclonal antibodies to MBPH has been
raised and their cross-reactivities with MBP and MBPH
tested. These results indicate that most monoclonalFIG. 1. Alignment of prepro-MBPs to hprepro-MBP
homolog. Identical amino acids among the prepro-MBPs
are enclosed in boxes. Half-cystines as determined for
hMBP are shaded with gray. Partially substituted O-
linked (!), fully substituted O-linked (^), N-linked (&)
and glycosaminoglycan (&) glycosylation sites are shown.The eosinophil granule major basic protein (MBP) is the
predominant proteinaceous molecule of the eosinophil
granule and comprises the granule core. Human MBP is a
13?8 kDa protein with a calculated isoelectric point of 11?4.
The cDNA sequence predicts initial translation of a
25?2 kDa pro-form containing a highly acidic proportion.
MBP functions as a cytotoxin and a cellular agonist. The
MBP pro-form is expressed in extravillous trophoblasts
(placental X cells) and circulates in the blood of pregnant
women as a complex with pregnancy associated plasma
protein-A (PAPP-A).
In a search for novel molecules expressed by eosinophils,
umbilical cord blood mononuclear cells (UCMC) were
stimulated with IL-5 and a cDNA library prepared. Large
scale cDNA sequencing of 8146 clones provided a picture
(Transcript Image) of IL-5 stimulated UCMC gene expres-
sion. Table 1 shows the percentage abundance of the 23
most prevalent transcripts. Among these, one cDNA
sequence specified the existence of a protein homologous
to MBP (and referred to here as the MBP homolog or
MBPH). The deduced amino acid sequence of prepro-
MBPH showed that the molecule is 64% homologous to
that of prepro-MBP. In keeping with the cDNA structure
of MBP, the homolog possesses an N-terminal signal
sequence, a highly acidic pro-portion and a basic MBP
portion. Remarkably, the theoretical pI of MBPH (pI 8?7)
is over 100-fold less basic than MBP (pI 11?4). Both MBP
and MBPH mRNAs are expressed by bone marrow,
whereas only MBP mRNA is expressed by placenta; neither
molecule is expressed in peripheral blood leukocytes,
presumably because of their terminal differentiation. Using
a specific monoclonal antibody (J191-12H11), MBPH was
identified and subsequently isolated from lysates of
eosinophil granules. Analysis of disulfide and sulfhydryl
groups showed five reactive cysteines in MBP and six in
MBPH; both molecules contained two disulfide bonds.
Extinction coecients for MBP and MBPH were exceed-
ingly high compared to other proteins at 3?67 and 3?32 (mg
ml71 cm71), respectively. Like MBP, MBPH is cytostimu-The start of pro-MBP (;) and MBP (+) are also marked.
Used with permission from ref. 2.
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TABLE 1. Twenty three most abundant transcripts of IL-5-differentiated UCC
Description of GenBankTM sequence* percentage abundance{
Eosinophil major basic protein mRNA 8?12
Eosinophil Charcot-Leyden crystal protein mRNA 2?98
UDP-GalNAc: polypeptide
N-acetylgalactosaminyltransferase mRNA 1?31
Eosinophil-derived neurotoxin mRNA 1?26
MBP homolog mRNA 1?14
Secretory granule proteoglycan core gene 1?09
Elongation factor EF-1-gene 1?06
Eosinophil peroxidase gene 0?95
Osteopontin mRNA 0?92
Ferritin light subunit mRNA 0?89
Cathepsin B mRNA 0?83
Transcription factor Sp1 mRNA 0?78
CpG island DNA genomic MseI fragment 0?72
Interferon-inducible mRNA 0?66
HLA-DR antigen-chain mRNA 0?54
Cathepsin D mRNA 0?50
Cytoplasmic-actin gene 0?49
3-Hydroxy-3-methylglutaryl coenzyme A synthase mRNA 0?47
NMB mRNA 0?47
-Interferon-inducible protein mRNA 0?40
Glyceraldehyde-3-phosphate dehydrogenase gene 0?40
Ribosomal protein S3a gene 0?40
Ia-associated invariant-chain gene 0?40
*All sequences listed are of human origin.
{Percentage abundance among 8146 total clonses sequenced.
Used with permission from ref.2.
1012 ABSTRACTSantibodies do not distinguish MBP from MBPH. Selection
of specific monoclonal antibodies to MBPH has permitted
establishment of a specific immunoassay for MBPH. In
this assay it is critical that MBPH be reduced and
alkylated in order to detect maximal reactivity. This
behavior of MBPH parallels that of MBP. Immunofluor-
escence examination of MBPH suggests that it is
present in eosinophils and basophils. By immunoelectron
microscopy MBPH has been localized to the eosinophil
granule. Finally, genomic clones for MBPH have been
identified and sequenced and chromosomal localization is
underway.
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The eosinophil ribonucleases, eosinophil-derived neurotox-
in (EDN) and eosinophil cationic protein (ECP) are among
the major secretory effector proteins of human eosinophilic
leukocytes, cells whose roles in host defense remain poorly
understood. Eosinophils have been implicated in the
pathophysiological process of wheezing in patients with
respiratory viral infections leading us to question the role of
eosinophil-derived ribonucleases in viral infections. Our
recent studies show that eosinophils are recruited to, and
degranulate in, the lung parenchyma of infants infected
with respiratory syncytial virus (RSV), a single stranded
RNA pathogen in the paramyxovirus family (1). These
